North East tech firm Kromek has announced a trio of new contracts worth more than £1.5m for its innovative D3S nuclear radiation detectors.
The Sedgefield firm works across security screening, medical and nuclear markets, and its D3S platform – which includes handheld “dirty bomb” detectors – is gaining traction with growing numbers of new customers.
Now the firm, which is carrying out expansion at its Sedgefield facility so it can ramp up production, has announced three new deals, with customers in the Ƶ, US and Europe, for D3S products.
The new contracts include a £1.1m contract from a Ƶ Government-related company to provide D3S-related technologies, plus a $389,000 (£307,000) contract from the US government’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), to provide D3S-related customisation for military use.
The third contract, worth €180,000 (£161,000), is from the European Commission’s Directorate-General for Migration and Home Affairs for the D3S-ID and drone-mounted D3S for wide-area monitoring.
The D3S suite of products were developed under the SIGMA programme, an initiative of the US Department of Defense’s Defense Advanced Research Projects Agency, (DARPA) and they are now sold in 18 countries across Europe and Asia as well as in the US.
The SIGMA programme’s aim was to revolutionise come up with new ways to counter nuclear terrorism, by developing more capable radiation detectors while lowering costs.
Arnab Basu, CEO of Kromek, said: “The D3S platform continues to gain traction in the US and the rest of the world.
“We are working with a number of high value-customers in a number of countries for deployment and implementation of this technology.
“These new contracts are great examples of the commercial progress in this area as well as the varied security and military applications for our D3S family of products.”
Last week Kromek revealed its annual turnover had reached £14.5m. Adjusted Ebitda grew fourfold to £2m and the pre-tax loss for the year narrowed by 48% to £1.3m, while the operating loss more than halved from £2.3m to £906,000.
